The issue of the cost of pharmaceutical products has been questioned for quite some time, but the industry has been unable to deliver concrete answers. Why exactly are pharmaceuticals so expensive? In the late 1950s, the same...
Read More‘Funding Biopharma: Strategies for Reaching Investors in a Financial Crisis’ Draws Regional Biopharmaceutical Executives, Investment Leaders BASKING RIDGE, N.J., June 18 /PRNewswire/ — Biotech companies...
Read MoreBelow is the press release report released today following up on a workshop held in November 2008. Access to report and press release are available at http://www.ftc.gov/opa/2009/06/biologics.shtm. FTC Releases Report on...
Read MoreProduction of recombinant protein drugs starts out with the selection of a cell line. This decision is crucial to avoid increased costs down the line. Once a suitable cell line has been established, further development and...
Read MoreRegenerative medicine is finally enjoying advancements at least equivalent to those of other areas. Given that its subject matter is the reduction of degeneration and increase of tissue repair, this area of medicine required a...
Read More
Testimonial
Smart Pharmaceutical Consulting has made a major contribution to our manufacturing strategy and how we plan to operate our plant in the future.